✦ LIBER ✦

Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain

✍ Scribed by Crespo, Carlos; Moreno, Estela; Sierra, Jordi; Serip, Suzan; Rubio, Marta

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A cost-effectiveness analysis of using a

✍ Gidwani, Risha; Khan, Zeba M.; Fenaux, Pierre; Beach, C. L.; Pashos, Chris L. 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 256 KB

PCN65 Cost-Effectiveness Analysis of Hyp

✍ Cantor, E.; Izquierdo, C. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Synergistic induction of PI-PLCβ1 signal

✍ Follo, M Y; Finelli, C; Mongiorgi, S; Clissa, C; Chiarini, F; Ramazzotti, G; Pao 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 671 KB

Cost-effectiveness Analysis in the Treat

✍ Lete, I.; Calaf, J.; Crespo, C.; Canals, I.; Espinós, B.; Cristóbal, I. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-effectiveness analysis of interfero

✍ J.L González-Larriba; S Serrano; M Alvarez-Mon; F Camacho; M.A Casado; J.L Dı́az 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 147 KB

P-311 Interim analysis of phase II rando

✍ Sanchez-Garcia, J.; Falantes, J.; Medina, A.; Hernandez-Mohedo, F.; Torres-Sabar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 72 KB